ASCO 2023 | Combining whole body-MRI & PET-CT to improve the diagnosis, stratification, and treatment of myeloma
Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, explores the rationale for combining whole-body magnetic resonance imaging (WB-MRI) and PET-CT scanning in the diagnosis and risk stratification of patients with newly diagnosed and relapsed/refractory (R/R) multiple myeloma, and high-risk smoldering multiple myeloma. Dr Cerchione also highlights the potential of integrating these techniques with molecular data to optimize diagnosis and treatment decisions in patients with multiple myeloma. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
